ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

TELA TELA Bio Inc

4.63
0.00 (0.00%)
Pre Mercado
Última actualización: 08:03:46
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
TELA Bio Inc TELA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 4.63 08:03:46
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.63
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202406:00GLOBETELA Bio to Announce First Quarter 2024 Financial Results
15/4/202406:00GLOBETELA Bio Announces U.S. Commercial Launch of..
08/4/202406:00GLOBETELA Bio Welcomes Acclaimed Surgeon as Vice President of..
21/3/202415:05GLOBETELA Bio Achieves Record Fourth Quarter and Full Year 2023..
21/3/202406:00GLOBETELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the..
20/3/202406:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
29/2/202406:00GLOBETELA Bio to Announce Fourth Quarter and Full Year 2023..
27/2/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
16/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:05EDGAR2Form 3/A - Initial statement of beneficial ownership of..
14/2/202416:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202405:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/1/202415:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
15/12/202315:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
07/12/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:00GLOBETELA Bio to Take Part in Connecting the Dots
16/11/202306:00GLOBETELA Bio to Participate in Piper Sandler’s 35th Annual..
14/11/202319:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:44EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202315:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
09/11/202315:05GLOBETELA Bio Reports Third Quarter 2023 Financial Results
26/10/202306:00GLOBETELA Bio to Announce Third Quarter 2023 Financial Results
20/10/202315:06EDGAR2Form 8-K - Current report
06/10/202310:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/9/202315:05EDGAR2Form 8-K - Current report
18/9/202315:05GLOBETELA Bio to Participate in the Gilmartin Group Emerging..
16/8/202306:15EDGAR2Form 8-K - Current report
16/8/202306:00GLOBETELA Bio Announces U.S. Commercial Launch of OviTex® PRS..
10/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:05EDGAR2Form 8-K - Current report
09/8/202315:03GLOBETELA Bio Reports Second Quarter 2023 Financial Results
04/8/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202315:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/8/202315:02GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
26/7/202306:00GLOBETELA Bio to Announce Second Quarter 2023 Financial Results..
15/6/202306:00GLOBENew Survey Finds Strong Consumer Preference for More Natural..
25/5/202306:00GLOBETELA Bio to Participate in the Jefferies Global Healthcare..
19/5/202306:00GLOBETELA Bio Invests in Surgeon Training and Education with..
11/5/202315:02GLOBETELA Bio Reports First Quarter 2023 Financial Results
09/5/202306:00GLOBETELA Bio Supports Diversity and Inclusion at International..
08/5/202315:30GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..

Su Consulta Reciente

Delayed Upgrade Clock